This phase II trial compares the effect of adding triapine to lutetium Lu 177 dotatate versus lutetium Lu 177 dotatate alone (standard therapy) in shrinking tumors or slowing tumor growth in patients with neuroendocrine tumors that have spread from…
- Investigator
- Kathryn E Hitchcock
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All